Shivaji Dasgupta, an autonomous Brand Consultant, writes that India’s obsession with shortcuts risks turning a breakthrough ...

Mounjaro wins bragging rights over Ozempic in a new weight-loss study—though it's one that was funded by the maker of ...

Meanwhile, the company continues to expand Mounjaro internationally. The drug is now available in 40 countries, and recently launched in India and Mexico. Lilly will continue to bring Mounjaro to ...

One of the highlights of Eli Lilly's third-quarter results was the rapid uptake of new type 2 diabetes therapy Mounjaro, which added more than $97 million in US sales alone in what has been ...

"Lilly had a solid start to the year, with 45% year-over-year revenue growth driven by strong sales of Mounjaro and Zepbound," said David A. Ricks, Lilly chair and CEO. "Our pipeline continued to ...

while another link invites visitors to “learn more” about Mounjaro. In a further play on the musical theme of the campaign, Lilly has teamed up with iHeartRadio to get the word out.

He is speaking publicly for the first time about having the condition and using Mounjaro, in partnership with its manufacturer, Eli Lilly. The active ingredient in GLP-1s mimics a hormone of the ...

Stonestreet — alongside his mother Jamey — is now a spokesperson for Eli Lilly and Company, maker of Mounjaro. He admits that because the medication worked so well for him, he felt committed ...

Eli Lilly LLY2.48%increase; green up pointing triangle revenue surged in the latest quarter on steady sales of Mounjaro and other weight-loss treatments in its portfolio. The drug maker logged net ...

Zepbound was ahead by $32 million while Mounjaro came in ahead by $70 million. Read more about Eli Lilly's stock moves and today's market action. Still, Eli Lilly holds the lead in the current ...

Compounded tirzepatide contains the same active ingredient as Mounjaro, but its dosage and some ingredients may differ from Mounjaro. The Food and Drug Administration (FDA) does not regulate the ...